Skip to content

APTALIS PHARMA INC

CIK 0001444570

← back to feed
Revenue (TTM)
$449.98M
+32.7% YoY Q1 Feb 2012
Net Income (TTM)
−$69.17M
−10.3% YoY Q1 Feb 2012
EPS Diluted (TTM)
—
Q1 Feb 2012
Gross Margin
—
Q1 Feb 2012
Operating Margin
-0.6%
Q1 Feb 2012
Net Margin
-15.4%
Q1 Feb 2012
Free Cash Flow (TTM)
−$56.42M
Q1 Feb 2012
Cash
$132.01M
Q1 Feb 2012
Total Debt
$974.89M
Q1 Feb 2012
Shares Outstanding
100 sh
Q1 Feb 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings